NORMA Group Announces EUR 50 Million Goodwill Impairment in EMEA Region

NORMA Group SE reported a significant goodwill impairment of approximately EUR 50 million in the EMEA region as of September 30, 2025. This non-cash impairment emerged during the preparation of the company's third-quarter Interim Statement, resulting from mandatory impairment tests based on revised revenue forecasts. While this impairment will affect post-tax consolidated earnings, it will not result in any cash outflow.

Despite the impairment, NORMA Group's guidance on 2025 Group Sales and adjusted EBIT margins remains unchanged. The final accounts are still under preparation, with the third-quarter Interim Statement scheduled for release on November 4. The adjustments in forecasts are aimed at aligning the financials with current market conditions without altering operational targets. Investors are advised that these changes do not impact the company's strategic financial outlook.